Share

October 2016; 2 (5) Clinical/Scientific NotesOpen Access

Outdated risk assessment in a family with Duchenne dystrophy: Implications for duty to reassess

Lauren Bogue, Sindhu Ramchandren
First published October 5, 2016, DOI: https://doi.org/10.1212/NXG.0000000000000103
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
510

Share

Article Information

vol. 2 no. 5 e103
DOI: 
https://doi.org/10.1212/NXG.0000000000000103
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2376-7839
History: 
  • Received June 20, 2016
  • Accepted in final form August 3, 2016
  • First Published October 5, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Lauren Bogue, MS and
    2. Sindhu Ramchandren, MD, MS
  1. Lauren Bogue, MS and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Sindhu Ramchandren, MD, MS
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. (1) NIH K23NS072279; Role: PI; Year(s): 09/01/2011- 08/31/2015

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Parent Project Muscular Dystrophy (L.B.), Hackensack, NJ; and Department of Neurology (L.B., S.R.), University of Michigan, Ann Arbor.
  1. Correspondence to Dr. Ramchandren: sindhur{at}umich.edu
View Full Text

Article usage

Article usage: October 2016 to April 2023

AbstractFullPdfSource
Oct 201636122640Highwire
Nov 20168717015Highwire
Dec 20161465Highwire
Jan 20171317Highwire
Feb 20171524Highwire
Mar 20171142Highwire
Apr 2017842Highwire
May 2017865Highwire
Jun 2017512Highwire
Jul 2017422Highwire
Aug 2017320Highwire
Sep 2017210Highwire
Oct 2017354Highwire
Nov 20171014Highwire
Dec 2017051Highwire
Jan 20181103Highwire
Feb 2018091Highwire
Mar 20180291Highwire
Apr 20180354Highwire
May 20180415Highwire
Jun 20180374Highwire
Jul 20180366Highwire
Aug 20181311Highwire
Sep 20180224Highwire
Oct 20180297Highwire
Nov 20180434Highwire
Dec 201801106Highwire
Jan 20193946Highwire
Feb 20196795Highwire
Mar 201953413Highwire
Apr 20195299Highwire
May 201922910Highwire
Jun 201943512Highwire
Jul 20190516Highwire
Aug 201911210Highwire
Sep 20190113Highwire
Oct 201912414Highwire
Nov 20190124Highwire
Dec 20190182Highwire
Jan 20201711Highwire
Feb 2020047Highwire
Mar 20204107Highwire
Apr 20201176Highwire
May 20201167Highwire
Jun 20201185Highwire
Jul 202032113Highwire
Aug 2020086Highwire
Sep 20203169Highwire
Oct 202012010Highwire
Nov 20200124Highwire
Dec 20201172Highwire
Jan 2021087Highwire
Feb 20211126Highwire
Mar 20210103Highwire
Apr 20211181Highwire
May 20213157Highwire
Jun 20213171Highwire
Jul 2021096Highwire
Aug 2021182Highwire
Sep 2021067Highwire
Oct 202142720Highwire
Nov 202101011Highwire
Dec 20211133Highwire
Jan 2022155Highwire
Feb 20221155Highwire
Mar 20221278Highwire
Apr 2022025Highwire
May 202211313Highwire
Jun 20221113Highwire
Jul 2022052Highwire
Aug 2022087Highwire
Sep 20220178Highwire
Oct 202202712Highwire
Nov 202207122Highwire
Dec 20220177Highwire
Jan 202313010Highwire
Feb 20230164Highwire
Mar 2023134Highwire
Apr 2023041Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles